Clinical Trials
All Clinical Trials - Page 18 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06045221Phase 3Completed
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
Semaglutide
- NCT06037252Phase 2Active Not Recruiting
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
Tirzepatide
- NCT06023095Phase 1Completed
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
Orforglipron
- NCT06047548Phase 3Completed
A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Tirzepatide
- NCT06739044Phase 3Completed
Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes
Semaglutide
- NCT06024356N/ACompleted
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer
Thymosin-Alpha-1
- NCT07309094N/ARecruiting
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Tirzepatide
- NCT06064006Phase 2Completed
A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the Skin
Amycretin
- NCT06049329Phase 1Completed
A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity
Amycretin
- NCT06009653Phase 4Withdrawn
Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
Tirzepatide
- NCT06045260Phase 2Recruiting
"Receptor Radionuclide Therapy With 177Lu-DOTATOC
Octreotide
- NCT06039826Phase 1Completed
A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
Retatrutide
- NCT05894239Phase 3Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Gonadorelin
- NCT06344247N/AUnknown
Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease
Semaglutide
- NCT06178146Phase 4Unknown
Thymosin Alpha-1 for irAE Secondary to ICIs
Thymosin-Alpha-1
- NCT06331286N/AUnknown
The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity
Dulaglutide
- NCT06003465Phase 1Completed
A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
Retatrutide
- NCT05724134Phase 1Completed
Pancreatic Clamp in NAFLD
Octreotide
- NCT06061354Phase 4Unknown
Teriparatide on Maxillary Sinus Floor Osseointegration
Teriparatide
- NCT06062719Phase 2/Phase 3Unknown
Role of Octreotide in Non Variceal Bleeding
Octreotide
- NCT05963022Phase 3Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)
Tirzepatide
- NCT06143033N/ACompleted
A Clinical Trial to Evaluate the Effects of an Eye Serum on Improving the Appearance of the Periorbital Area
Argireline
- NCT05996848Phase 3Completed
A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose Weight
Semaglutide
- NCT06085976Phase 2Unknown
Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.
Octreotide
- NCT05996874Phase 1Completed
A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participants
Semaglutide
- NCT06256549Phase 2Unknown
A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus
Semaglutide
- NCT05617885Phase 1Completed
Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer
Gonadorelin
- NCT05971940Phase 3Completed
A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
Orforglipron
- NCT05984238N/ACompleted
A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy
Semaglutide
- NCT05931367Phase 3Completed
A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee
Retatrutide
- NCT05990374N/AUnknown
Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years
Tirzepatide
- NCT05897372Phase 2Terminated
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
Semaglutide
- NCT06091735N/ACompleted
Clinical Study of Bowel Preparation Before Colonoscopy
Linaclotide
- NCT05978713Phase 1Completed
A Study of Tirzepatide (LY3298176) in Healthy Lactating Females
Tirzepatide
- NCT05931380Phase 3Completed
A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease
Orforglipron
- NCT05924256Phase 2Active Not Recruiting
A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing
Gonadorelin
- NCT06005012Phase 2Active Not Recruiting
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
Semaglutide
- NCT06139419Phase 2Completed
The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC
Thymosin-Alpha-1
- NCT05936151Phase 2Completed
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Retatrutide
- NCT05669664Phase 2Active Not Recruiting
Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers
Gonadorelin
- NCT05945420Phase 4Unknown
Adding Desmopressin to Tamsulosin for Treatment of BPH
Desmopressin
- NCT05959096Phase 1Completed
A Study of LY3437943 in Healthy Participants With a High Body Mass Index
Retatrutide
- NCT05916560Phase 1Completed
A Study of LY3437943 in Participants With Impaired and Normal Liver Function
Retatrutide
- NCT05936138Phase 1Completed
A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.
Orforglipron
- NCT05929079Phase 3Completed
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
Retatrutide
- NCT05929066Phase 3Completed
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
Retatrutide
- NCT05812183Phase 4Withdrawn
Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity
Tirzepatide
- NCT05891587Phase 2Completed
Semaglutide Therapy for Alcohol Reduction - Tulsa
Semaglutide
- NCT05726227Phase 3Active Not Recruiting
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight
Semaglutide
- NCT05884255Phase 3Recruiting
An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.
Octreotide